Skip to main content
Fig. 9 | Clinical Proteomics

Fig. 9

From: Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Fig. 9

Immunohistochemistry of FFPE cerebral melanoma metastases cohort (n = 22). Evaluation of good responders (n = 7) versus poor responders (n = 15) shows significant different expression of he T cell marker CD3 (orange; p value = 0.002), CD4 (green; p value = 0.025) and CD8 (blue; p value = 0.007) visualized in the scatter plot (a) and by examples of the staining results (b)

Back to article page

Clinical Proteomics

ISSN: 1559-0275